Cover Image

Progress in Clinical Pharmacology in China: An Ongoing Evolution

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Liang Zhao, Piet H. van der Graaf
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype‐Guided Precision Medicine
by: Liang Zhao, et al.
Published: (2024)

History and Evolution of Innovations in Clinical Pharmacology
by: Lawrence J. Lesko, et al.
Published: (2025)

Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
by: Qi Liu, et al.
Published: (2024)

Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine
by: Iris K. Minichmayr, et al.
Published: (2024)

Innovations in Clinical Pharmacology: Shaping the Future of Evidence Generation in Research, Development, and Utilization of Medicines
by: Karthik Venkatakrishnan, et al.
Published: (2025)

Interchanging Biosimilars Using Proteomics
by: Piet H. van der Graaf, et al.
Published: (2025)

Weaning off ThoroughQTStudies
by: Mai Mehanna, et al.
Published: (2024)

Best Practices for Pharmacokinetic Studies of New Chemical Entities
by: Ya‐Feng Wen, et al.
Published: (2024)

Reflections on Model‐Informed Drug Development
by: Lawrence J. Lesko, et al.
Published: (2024)

Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
by: Chanchala Kaddi, et al.
Published: (2024)

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
by: Georgi I. Kapitanov, et al.
Published: (2025)

Ongoing Pharmacological Developments in SLC6A1 Research & Treatment
by: Melissa B. DeLeeuw, et al.
Published: (2024)

Moving the Needle for Oncology Dose Optimization: A Call for Action
by: Karthik Venkatakrishnan, et al.
Published: (2024)

Model‐Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC : A QSP Model for Alpelisib and Tipifarnib Combination
by: Jaehee Shim, et al.
Published: (2026)

The Future of Clinical Translational Pharmacology
by: Matthew L. Rizk, et al.
Published: (2026)

American Society for Clinical Pharmacology and Therapeutics
Published: (2026)

The Role for Clinical Translational Pharmacology in Advancing Pharmacoequity
by: Sonya Tang Girdwood, et al.
Published: (2025)

Seasons of Growth: Reflections on the CPT Editor‐in‐Training Program
by: Matthijs W. van Hoogdalem, et al.
Published: (2025)

Clinical Pharmacology Considerations for the “Off‐the‐Shelf” Allogeneic Cell Therapies
by: Hardik Mody, et al.
Published: (2024)

Correction to “Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies”
Published: (2025)

From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology
by: Karen Rowland Yeo, et al.
Published: (2026)

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development
by: Robin DiFrancesco, et al.
Published: (2026)

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology
by: Aaron S. Devanathan, et al.
Published: (2025)

New Horizons for Clinical Pharmacology & Therapeutics : Global Outreach for Optimal Patient Outcomes
by: Karen Rowland Yeo
Published: (2025)

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
by: Mohamed Elmeliegy, et al.
Published: (2024)

Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins
by: Yow‐Ming C. Wang, et al.
Published: (2024)

Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
by: John D. Davis, et al.
Published: (2024)

Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
by: Ting Wang, et al.
Published: (2025)

Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
by: Prathap Nagaraja Shastri, et al.
Published: (2024)

HIV Pharmacology Data Repository: Setting the New Information‐Sharing Standard for Clinical and Preclinical Pharmacokinetic Studies
by: Lauren A.R. Tompkins, et al.
Published: (2025)

Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA‐Approved Bispecific Antibodies in Oncology
by: KyoungSoo Lim, et al.
Published: (2024)

Progress, Pitfalls, and Impact of AI‐Driven Clinical Trials
by: Dominika Wilczok, et al.
Published: (2024)

Leading the Way: Multi‐Drug Resistance Protein (MDR1) and Clinical Pharmacology—Commentary on Kim et al.
by: Kathleen M. Giacomini
Published: (2025)

Optimizing Clinical Translation of Bispecific T‐cell Engagers through Context Unification with a Quantitative Systems Pharmacology Model
by: Xiaozhi Liao, et al.
Published: (2024)

A Comparative Clinical Pharmacology Analysis of FDA‐Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology
by: Huy X. Ngo, et al.
Published: (2024)

Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making
by: Linh M. Van, et al.
Published: (2025)

Modeling Supports Combinatorial Effects Between Pharmacological and Non‐Pharmacological Interventions to Prevent Opioid‐Induced Cardiac Arrest
by: Bradlee Thrasher, et al.
Published: (2026)

The Potential of Disease Progression Modeling to Advance Clinical Development and Decision Making
by: Mary Summer Starling, et al.
Published: (2024)

Recommended Phase II Doses of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma From MonumenTAL‐1: Clinical Pharmacology Results
by: Jue Gong, et al.
Published: (2025)

Insights into Clinical Trials for Drugs Targeting MASLD: Progress, Challenges, and Future Directions
by: Yu Wu, et al.
Published: (2025)